Journal
JOURNAL OF DENTAL RESEARCH
Volume 88, Issue 12, Pages 1148-1153Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/0022034509347168
Keywords
remineralization; CPP-ACP; white-spot lesion; post-orthodontic; clinical trial
Categories
Funding
- CRC for Oral Health Science
- GC Corporation, Japan
Ask authors/readers for more resources
Orthodontic patients have an increased risk of white-spot lesion formation. A clinical trial was conducted to test whether, in a post-orthodontic population using fluoride toothpastes and receiving supervised fluoride mouthrinses, more lesions would regress in participants using a remineralizing cream containing casein phosphopeptide-amorphous calcium phosphate compared with a placebo. Forty-five participants (aged 12-18 yrs) with 408 white-spot lesions were recruited, with 23 participants randomized to the remineralizing cream and 22 to the placebo. Product was applied twice daily after fluoride toothpaste use for 12 weeks. Clinical assessments were performed according to ICDAS II criteria. Transitions between examinations were coded as progressing, regressing, or stable. Ninety-two percent of lesions were assessed as code 2 or 3. For these lesions, 31% more had regressed with the remineralizing cream than with the placebo (OR = 2.3, P = 0.04) at 12 weeks. Significantly more post-orthodontic white-spot lesions regressed with the remineralizing cream compared with a placebo over 12 weeks. Abbreviations: CPP-ACP, calcium phosphopeptide-amorphouscalcium phosphate; ICDAS, International Caries Detection and Assessment System.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available